BE869043A - Mecanisme a cle prisonniere - Google Patents

Mecanisme a cle prisonniere

Info

Publication number
BE869043A
BE869043A BE1008984A BE1008984A BE869043A BE 869043 A BE869043 A BE 869043A BE 1008984 A BE1008984 A BE 1008984A BE 1008984 A BE1008984 A BE 1008984A BE 869043 A BE869043 A BE 869043A
Authority
BE
Belgium
Prior art keywords
prisoner
key mechanism
key
prisoner key
Prior art date
Application number
BE1008984A
Other languages
English (en)
Inventor
J G Allemann
M W Grey
Original Assignee
Norris Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norris Industries filed Critical Norris Industries
Publication of BE869043A publication Critical patent/BE869043A/fr

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
    • E05B—LOCKS; ACCESSORIES THEREFOR; HANDCUFFS
    • E05B11/00—Devices preventing keys from being removed from the lock ; Devices preventing falling or pushing out of keys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S70/00—Locks
    • Y10S70/60—Opposed cylinders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T70/00—Locks
    • Y10T70/70—Operating mechanism
    • Y10T70/7441—Key
    • Y10T70/7486—Single key
    • Y10T70/7508—Tumbler type
    • Y10T70/7559—Cylinder type
    • Y10T70/7667—Operating elements, parts and adjuncts
    • Y10T70/7706—Operating connections
    • Y10T70/7712—Rollbacks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T70/00—Locks
    • Y10T70/70—Operating mechanism
    • Y10T70/7441—Key
    • Y10T70/7768—Key-removal preventing
BE1008984A 1977-12-20 1978-07-17 Mecanisme a cle prisonniere BE869043A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,558 US4109496A (en) 1977-12-20 1977-12-20 Trapped key mechanism

Publications (1)

Publication Number Publication Date
BE869043A true BE869043A (fr) 1979-01-17

Family

ID=25338762

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1008984A BE869043A (fr) 1977-12-20 1978-07-17 Mecanisme a cle prisonniere

Country Status (4)

Country Link
US (1) US4109496A (fr)
BE (1) BE869043A (fr)
CA (1) CA1089246A (fr)
GB (1) GB2011990B (fr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228669A (en) * 1978-07-03 1980-10-21 Kysor Industrial Corporation Double cylinder lock with key retention
US4254648A (en) * 1979-02-21 1981-03-10 Norris Industries, Inc. Inner locking cylinder with captive key
US4315420A (en) * 1980-04-11 1982-02-16 Oliver Ronald N Retained key double cylinder deadbolt
US4369642A (en) * 1981-03-25 1983-01-25 Norris Industries, Inc. Detained key assembly
US4698989A (en) * 1986-09-26 1987-10-13 Kwikset Corporation Double cylinder lock assembly
US4793166A (en) * 1986-12-12 1988-12-27 Marks George R Multi-use lock cylinder
US5269162A (en) * 1990-10-12 1993-12-14 Emhart Inc. Cylinder lock
US5193372A (en) * 1991-04-19 1993-03-16 Dom-Sicherheitstechnik Gmbh & Co Kg Lock cylinder
US5140843A (en) * 1992-01-27 1992-08-25 Krueger Owen A Lock conversion mechanism
US5372021A (en) * 1992-10-30 1994-12-13 Ideaz International, Inc. Key control device and method therefor
US6207371B1 (en) 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US6855545B1 (en) 1996-10-04 2005-02-15 Lexicon Genetics Inc. Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US5914394A (en) * 1997-03-27 1999-06-22 Millenium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
US5866412A (en) * 1997-03-27 1999-02-02 Millennium Pharmaceuticals, Inc. Chromosome 18 marker
US5939316A (en) * 1997-03-27 1999-08-17 Millennium Pharmaceuticals, Inc. Chromosome 18 marker
US5955355A (en) * 1997-03-27 1999-09-21 Millennium Pharmaceuticals, Inc. Chromosome 18 marker
US5878613A (en) * 1997-08-06 1999-03-09 Secure Concepts, Ltd. Key retaining lock box
AU782067B2 (en) 1999-12-20 2005-06-30 Immunex Corporation TWEAK receptor
WO2001064882A2 (fr) 2000-02-29 2001-09-07 Millennium Pharmaceuticals, Inc. Recepteurs couples a une proteine g, numerotees 1983, 52881, 2398, 45449, 50289, et 52872, et utilisations correspondantes
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US20080194022A1 (en) * 2000-08-03 2008-08-14 Clarke Michael F Isolation and use of solid tumor stem cells
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US6803211B2 (en) * 2000-08-25 2004-10-12 Pfizer Inc. Methods and compositions for diagnosing and treating disorders involving angiogenesis
EP1197550A3 (fr) * 2000-08-25 2002-11-20 Pfizer Products Inc. Méthodes et compositions pour diagnostiquer et traiter des troubles associés à l'angiogenèse
US6729169B2 (en) 2001-03-27 2004-05-04 Randall L. Moore Dual cylinder deadbolt adjunct
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
EP2354156A3 (fr) 2001-08-14 2011-11-16 Sentigen Biosciences, Inc. Acides nucléiques et protéines de gènes de récepteur odorant OR83B d'insectes et utilisations associées
EP1421214A4 (fr) * 2001-08-27 2005-11-02 Tularik Inc Oncogenes amplifies et leur implication dans le cancer
KR100942880B1 (ko) 2001-08-29 2010-02-17 제넨테크, 인크. 유사분열촉진 활성을 가진 Ｂｖ８ 핵산 및 폴리펩티드
AU2002356898A1 (en) * 2001-11-15 2003-06-10 Tularik Inc. Gene amplification and overexpression in cancer
IL162269A0 (en) 2001-12-05 2005-11-20 Baylor College Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
AU2002366803A1 (en) 2001-12-19 2003-07-09 Millennium Pharmaceuticals, Inc. Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
AU2002359697A1 (en) * 2001-12-20 2003-07-09 Tularik Inc. Identification of an amplified gene and target for drug intervention
WO2003057916A2 (fr) 2002-01-09 2003-07-17 Riken Profils du cancer
WO2003079982A2 (fr) * 2002-03-19 2003-10-02 Tularik Inc. Amplification de genes en cas de cancer
US20060052320A1 (en) * 2002-05-06 2006-03-09 Limin Li Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
AU2003269903B2 (en) 2002-07-12 2009-07-23 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Assays for assembly of ebola virus nucleocapsids
WO2004015063A2 (fr) * 2002-08-07 2004-02-19 Tularik Inc. Amplification et surexpression d'oncogenes
GB2411692B (en) * 2002-10-15 2006-10-04 Geoffrey David Miles Improvements in or relating to locks
CA2506243A1 (fr) * 2002-11-19 2004-06-03 Amgen Inc. Genes amplifies impliques dans un cancer
EP2112229A3 (fr) 2002-11-25 2009-12-02 Sequenom, Inc. Procédés d'identification du risque du cancer du sein et traitements associés
MXPA05009743A (es) 2003-03-12 2006-03-09 Genentech Inc Composiciones con actividad hematopoyetica e inmune.
EP2003196A3 (fr) 2003-06-09 2009-01-07 The Regents of the University of Michigan Compositions et procédés de diagnostic et de traitement des cancers
AU2004249193A1 (en) * 2003-06-20 2004-12-29 Amgen Inc. Gene amplification and overexpression in cancer
WO2005074633A2 (fr) * 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions et procédés permettant de caractériser, de réguler, de diagnostiquer et de traiter des cancers
WO2005092924A2 (fr) 2004-02-24 2005-10-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rab9a, rab11a et leurs modulateurs lies a une maladie infectieuse
AU2005247332A1 (en) * 2004-04-30 2005-12-08 Corthera, Inc. Methods and compositions for control of fetal growth via modulation of relaxin
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2006138275A2 (fr) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions et procedes de traitement et de diagnostic de cancer
US7718369B2 (en) 2005-09-12 2010-05-18 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) * 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US8652467B2 (en) * 2005-10-14 2014-02-18 The Regents Of The University Of Michigan Dek protein compositions and methods of using the same
WO2007050554A2 (fr) * 2005-10-25 2007-05-03 The Trustees Of Columbia University In The City Of New York Identification de composes modulant l'activite des proteines du domaine phb, et compositions obtenues a partir de ces composes
PT2500360E (pt) 2005-10-31 2015-10-15 Oncomed Pharm Inc Composições e métodos para diagnóstico e tratamento do cancro
US7723112B2 (en) * 2005-10-31 2010-05-25 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
WO2007056113A2 (fr) * 2005-11-02 2007-05-18 Cylene Pharmaceuticals, Inc. Procedes de ciblage de sequences quadruplex
EP1984400B1 (fr) 2006-01-05 2012-11-28 Immune Disease Institute, Inc. Régulateurs de nfat
WO2008121102A2 (fr) * 2006-02-21 2008-10-09 The Regents Of The University Of Michigan Traitement du cancer par un antagoniste de la voie de signalisation hedgehog
EP2035439A4 (fr) 2006-06-05 2010-01-13 Cancer Care Ontario Évaluation de risque pour cancer colorectal
US7572618B2 (en) 2006-06-30 2009-08-11 Bristol-Myers Squibb Company Polynucleotides encoding novel PCSK9 variants
US8978426B2 (en) * 2006-11-07 2015-03-17 Pacific Lock Company Hidden shackle lock incorporating a “key-in-knob” (KiK) cylinder
WO2008092002A2 (fr) * 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions et procédés pour le traitement et le diagnostic du cancer du pancréas
CA2679954A1 (fr) 2007-03-05 2008-09-12 Cancer Care Ontario Evaluation du risque de cancer colorectal
KR20100031528A (ko) 2007-06-01 2010-03-22 더 트러스티즈 오브 프린스턴 유니버시티 숙주세포 대사경로의 조절을 통한 바이러스 감염 치료
EP3009148B1 (fr) 2007-07-02 2018-08-22 Oncomed Pharmaceuticals, Inc. Compositions et procédés de traitement et de diagnostic d'un cancer
WO2009009431A2 (fr) 2007-07-06 2009-01-15 The Regents Of The University Of Michigan Réarrangements de gènes mipol1 -etv1
EP2167689B1 (fr) 2007-07-06 2012-10-31 The Regents Of The University Of Michigan Fusions géniques récurrentes dans le cancer de la prostate
US7895865B2 (en) * 2007-08-15 2011-03-01 Medeco Security Locks, Inc. Cylinder lock assembly with a tailpiece rotationally coupled to the cylinder plug
WO2009038770A2 (fr) * 2007-09-20 2009-03-26 University Of Massachusetts Cvip Neurotoxine botulique recombinante détoxifiée
US8709726B2 (en) * 2008-03-11 2014-04-29 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
ES2663536T3 (es) 2008-09-26 2018-04-13 Oncomed Pharmaceuticals, Inc. Agentes que se unen a receptores frizzled y usos de los mismos
KR101588547B1 (ko) 2008-11-11 2016-01-28 더 리젠츠 오브 더 유니버시티 오브 미시간 항-ｃｘｃｒ１ 조성물 및 방법
JP2012514475A (ja) 2009-01-09 2012-06-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 癌における再現性の遺伝子融合物
JP5800817B2 (ja) 2009-09-17 2015-10-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌における再発性遺伝子融合
US9926593B2 (en) 2009-12-22 2018-03-27 Sequenom, Inc. Processes and kits for identifying aneuploidy
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Ｗｎｔ拮抗劑及治療和篩選方法
EP3450979A3 (fr) 2010-03-17 2019-04-24 The Regents of The University of Michigan Utilisation d'épitopes de phage à des fins de profilage de la réponse immunitaire
CN102971337B (zh) 2010-04-01 2016-09-21 昂考梅德药品有限公司 卷曲蛋白结合药剂及其应用
DE102010038105B4 (de) * 2010-10-11 2012-05-24 André Haake Verfahren zur Kodierung eines Schlosses und Rohteil zur Durchführung dieses Verfahrens
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
CA2834218C (fr) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification d'une minorite d'especes d'acide nucleique utilisant des oligonucleotides inhibiteurs
US8474289B2 (en) 2011-11-28 2013-07-02 Southern Company Services, Inc. Locking systems
EP2820129A1 (fr) 2012-03-02 2015-01-07 Sequenom, Inc. Méthodes et procédés d'évaluation non effractive de variations génétiques
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014011928A1 (fr) 2012-07-13 2014-01-16 Sequenom, Inc. Procédés et compositions pour l'enrichissement basé sur la méthylation d'un échantillon maternel en acide nucléique fœtal, utiles pour les diagnostics prénatals non invasifs
US20160046997A1 (en) 2012-10-18 2016-02-18 Oslo Universitetssykehus Hf Biomarkers for cervical cancer
HK1212216A1 (en) 2012-10-23 2016-06-10 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
JP2016510411A (ja) 2013-02-04 2016-04-07 オンコメッド ファーマシューティカルズ インコーポレイテッド Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
EP2971100A1 (fr) 2013-03-13 2016-01-20 Sequenom, Inc. Amorces pour analyse de la méthylation de l'adn
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
US10107008B2 (en) 2013-09-15 2018-10-23 Pacific Lock Company Lock device
EP3736344A1 (fr) 2014-03-13 2020-11-11 Sequenom, Inc. Méthodes et procédés d'évaluation non invasive de variations génétiques
US10047547B2 (en) 2015-05-20 2018-08-14 Pacific Lock Company Locking link
WO2017087885A1 (fr) 2015-11-19 2017-05-26 Dana-Farber Cancer Institute, Inc. Méthodes d'identification de composés qui interfèrent avec les erreurs de routage des complexes baf liées à erg dans les cancers de la prostates liés à tmprss2-erg
US10619382B2 (en) 2016-02-29 2020-04-14 Pacific Lock Company Keyless lock system
USD930458S1 (en) 2016-09-30 2021-09-14 Pacific Lock Company Lock casing
CN112153984A (zh) 2018-01-30 2020-12-29 福宏治疗公司 化合物及其用途
WO2020081588A1 (fr) 2018-10-17 2020-04-23 Dana-Farber Cancer Institute, Inc. Complexes de remodelage de la chromatine de la famille swi/snf et leurs utilisations
US12384776B2 (en) 2019-01-29 2025-08-12 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2020160100A1 (fr) 2019-01-29 2020-08-06 Foghorn Therapeutics Inc. Composés et leurs utilisations
JP7561195B2 (ja) 2020-01-29 2024-10-03 フォグホーン セラピューティクス インコーポレイテッド 化合物及びその使用
US12383555B2 (en) 2020-05-20 2025-08-12 Foghorn Therapeutics Inc. Methods of treating cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US785228A (en) * 1904-04-29 1905-03-21 Byron Phelps Lock and latch.
US1454020A (en) * 1922-01-25 1923-05-01 American Hardware Corp Lock
US3938358A (en) * 1971-11-18 1976-02-17 David Doyle Pick-proof lock
US4028917A (en) * 1976-04-12 1977-06-14 Schlage Lock Company Key retaining cylinder for a lock

Also Published As

Publication number Publication date
GB2011990A (en) 1979-07-18
US4109496A (en) 1978-08-29
CA1089246A (fr) 1980-11-11
AU3802478A (en) 1980-03-20
GB2011990B (en) 1982-03-03

Similar Documents

Publication Publication Date Title
BE869043A (fr) Mecanisme a cle prisonniere
IT1102157B (it) Serratura a combinazione
IT1090655B (it) Serratura a combinazione
IT1102164B (it) Serratura a combinazione
IT7822020A0 (it) Dispositivo di chiusura a catenaccio.
DK155485C (da) Konditionerings-slaamaskine
MX145121A (es) Mejoras en un mecanismo de cerrojo para maletas
PL205461A1 (pl) Srodek chwastobojczy
IT1109075B (it) Serratura a permutazione
PL208435A1 (pl) Srodek chwastobojczy
PL207767A1 (pl) Srodek chwastobojczy
PL204307A1 (pl) Srodek chwastobojczy
IT1106928B (it) Serratura a combinazione
IT1192589B (it) Aloctina a
IT1100938B (it) Lucchetto a catena
PL203976A1 (pl) Srodek chwastobojczy
PL207194A1 (pl) Srodek chwastobojczy
BR7804623A (pt) Comutador a tecla
IT1098175B (it) Impianto a serrature
IT1117659B (it) Bicicletta a bitrasmissione
PL106564B1 (pl) Srodek chwastobojczy
IT1095070B (it) Dispositivo a serratura e chiave
PL195737A1 (pl) Srodek chwastobojczy
BE867656A (fr) Transtockeur a fourches ecartables
IT1087588B (it) Serratura a combinazione perfezionata